Author Correction: Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376

Correction to: Acta Pharmacologica Sinica 10.1038/s41401-022-00929-z, published online 30 June 2022

Issue:

1. After publication of our paper, we learned that we have overlooked several relevant GC376-M^Pro complex structures published previously (Fu et al., Nature Communications 2020, Vuong et al., Nature Communications 2020). Structural comparison reveals a very similar binding mode of our structure with the published structures. In this correction, we have discussed the similarity of these structures and added the references to the paper. We apologize for our oversight during the preparation of the paper.

2. After publication of our paper, we found that an error was introduced into the full name of SARS-COV-2 in first paragraph during the language polishing process after the acceptance of the paper.

Correct:

1. Add sentence “We also compared our structure to GC376-SARS- CoV-2 M^pro structure reported by Fu et al. [1] and Vuong et al. [2] and also found a similar binding mode.” after sentence “The conformation of SARS-CoV-2 Mpro-GC376 reported by another group [8] is similar to our structure, with the phenylmethyl groups at slightly different positions (Supplementary information, Fig. S1b).”.

2. Modify “sudden accuse respiratory syndrome coronavirus 2” in first paragraph to “severe acute respiratory syndrome coronavirus-2”.